Specify a stock or a cryptocurrency in the search bar to get a summary
Hexima Ltd
HXLHexima Limited does not have significant operations. It focuses on exploration of transactions with third parties, which could enable the value of the company's assets. Previously, the company was involved in the research and development of pezadeftide for the treatment of onychomycosis. Hexima Limited was incorporated in 1997 and is headquartered in Carlton, Australia. Address: C/-Acclime, Carlton, VIC, Australia, 3053
Analytics
WallStreet Target Price
1.13 AUDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures HXL
Dividend Analytics HXL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History HXL
Stock Valuation HXL
Financials HXL
Results | 2019 | Dynamics |